- Luglio 2024

Chavez-MacGregor M, Miao J, Pusztai L, et al.

Phase III randomized, placebo-controlled trial of endocrine therapy ± 1 year of everolimus in patients with high-risk, hormone receptor-positive, early-stage breast cancer

J Clin Oncol 2024 Jun 4:JCO2302344. Epub ahead of print

Simonpietro Marrocco Luglio 2024

Leggi abstract | Scarica ppt

---

Azim HA Jr, Niman SM, Partridge AH, et al.

Fertility preservation and assisted reproduction in patients with breast cancer interrupting adjuvant endocrine therapy to attempt pregnancy

J Clin Oncol 2024 May 29:JCO2302292. Epub ahead of print

Simonpietro Marrocco Luglio 2024

Leggi abstract | Scarica ppt

---

Cortés J, Hurvitz SA, O’Shaughnessy J, et al.

Randomized phase iii study of amcenestrant plus palbociclib versus letrozole plus palbociclib in estrogen receptor-positive, human epidermal growth factor receptor 2-negative advanced breast cancer: Primary results from AMEERA-5

J Clin Oncol 2024 Jun 18:JCO2302036. Epub ahead of print

Simonpietro Marrocco Luglio 2024

Leggi abstract | Scarica ppt

---

Tarantino p, Tayob N, Villacampa G, et al.

Adjuvant trastuzumab emtansine versus paclitaxel plus trastuzumab for stage i human epidermal growth factor receptor 2-positive breast cancer: 5-year results and correlative analyses from ATEMPT

J Clin Oncol 2024 Jun 27:JCO2302170. Epub ahead of print

Simonpietro Marrocco Luglio 2024

Leggi abstract | Scarica ppt

---

Dent R, André F, Gonçalves A, et al.

IMpassion132 double-blind randomised phase III trial of chemotherapy with or without atezolizumab for early relapsing unresectable locally advanced or metastatic triple-negative breast cancer

Ann Oncol 2024;35(7):630-642

Simonpietro Marrocco Luglio 2024

Leggi abstract | Scarica ppt

---

Xiao Q, Mao X, Ploner A, et al.

Cancer risks among first-degree relatives of women with a genetic predisposition to breast cancer

J Natl Cancer Inst 2024;116(6):911-919

Simonpietro Marrocco Luglio 2024

Leggi abstract

---

Ohnstad HO, Blix ES, Akslen LA, et al.

Impact of Prosigna test on adjuvant treatment decision in lymph node-negative early breast cancer-a prospective national multicentre study (EMIT-1)

ESMO Open 2024;9(6):103475

Simonpietro Marrocco Luglio 2024

Leggi abstract

---

Soldato D, Michiels S, Havas J, et al.

Dose/exposure relationship of exercise and distant recurrence in primary breast cancer

J Clin Oncol 2024 Jun 5:JCO2301959. Epub ahead of print

Simonpietro Marrocco Luglio 2024

Leggi abstract

---

Bostany G, Chen Y, Francisco L, et al.

Cardiac Dysfunction Among Breast Cancer Survivors: Role of Cardiotoxic Therapy and Cardiovascular Risk Factors

J Clin Oncol 2024 Jun 4:JCO2301779. Epub ahead of print

Simonpietro Marrocco Luglio 2024

Leggi abstract

---

Martín M, Lim E, Chavez-MacGregor M, et al.

Giredestrant for estrogen receptor-positive, HER2-negative, previously treated advanced breast cancer: results from the randomized, phase II acelERA breast cancer study

J Clin Oncol 2024;42(18):2149-2160

Simonpietro Marrocco Luglio 2024

Leggi abstract

---

Cortés J, Hurvitz SA, Im SA, et al.

Trastuzumab deruxtecan vs trastuzumab emtansine in HER2-positive metastatic breast cancer: long-term survival analysis of the DESTINY-Breast03 trial

Nat Med 2024 Jun 2. Epub ahead of print

Simonpietro Marrocco Luglio 2024

Leggi abstract

---

Zhang BX, Brantley KD, Rosenberg SM, et al.

Second primary non-breast cancers in young breast cancer survivors

Breast Cancer Res Treat 2024 Jun 10. Epub ahead of print

Simonpietro Marrocco Luglio 2024

Leggi abstract

---

Kang D, Cho J, Zhao D, et al.

Scalp cooling in preventing persistent chemotherapy-induced alopecia: a randomized controlled trial

J Clin Oncol 2024 Jun 6:JCO2302374. Epub ahead of print

Simonpietro Marrocco Luglio 2024

Leggi abstract

---

Chua AV Jr, Sheng H, Liang E, et al.

Epidemiology of early vs late recurrence among women with early-stage estrogen receptor-positive breast cancer in the pathways study

J Natl Cancer Inst 2024 Jun 6:djae128. Epub ahead of print

Simonpietro Marrocco Luglio 2024

Leggi abstract

---

Schmidt JA, Woolpert KM, Hjorth CF, et al.

Social characteristics and adherence to adjuvant endocrine therapy in premenopausal women with breast cancer

J Clin Oncol 2024 Jun 25:JCO2302643. Epub ahead of print

Simonpietro Marrocco Luglio 2024

Leggi abstract

---